Analysis: Chinese Drugmakers Gear Up in Race for Covid Treatments

(Blue View) — Chinese drug giant CSPC Pharmaceutical Group won regulatory approval last week to start clinical trials of a Covid-19 medicine it developed. The step was the latest development in the country’s effort to add ammunition for combating the pandemic.

The approval for clinical trials of the pill is the latest advance in CSPC’s Covid-related efforts on various fronts. The company has also launched clinical trials of its mRNA-based vaccine.